Original Source(s)
Related Content
FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure
Phase 3 data showed a 67% reduction in symptomatic infection among exposed household contacts who tested negative at baseline.
June 2, 2026
-
3 min
Troponin Testing and Early MI Discharge
Sixth-generation high-sensitivity cardiac troponin T assay classifies more patients below a low-risk threshold at presentation.
June 1, 2026
-
4 min